COCRYSTAL PHARMA INC (COCP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

19805 N. CREEK PARKWAY BOTHELL, WA 98011

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.

Data as of 2021-07-25 17:34:19 -0400
Market Cap111.114 Million Shares Outstanding97.469 Million Avg 30-day Volume1.65 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE4.04 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.99664 52-week High/Low3.46 / 0.76 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -32.6049
Data provided by IEX Cloud
View SEC Filings from COCP instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 35 33 6.06% 10 (0.59%) 10 (0.58%) 0.0%
13F shares: 9.742 Million 10.184 Million -4.34% 5.832 Million 6.433 Million -9.34%
% Ownership 13.6311 14.8533 -8.23% 8.1608 9.3828 -13.02%
New Positions: 9 11 -18.18% 2 2 0.0%
Increased Positions 9 7 28.57% 4 2 100.0%
Closed Positions 7 5 40.0% 2 2 0.0%
Reduced Positions 7 7 0.0% 2
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding COCP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COCP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PFENNIGER RICHARD C JR

  • Director
0 2021-05-27 1

SCHINAZI RAYMOND F

  • 10% Owner
7,674,960 2021-05-04 1

LEE SAM PRESIDENT

  • Officer
0 2020-12-31 1

WILCOX GARY CHIEF EXECUTIVE OFFICER

  • Officer
0 2020-06-22 0

KORNBERG ROGER D.

  • Director
0 2020-06-22 0

RUBIN STEVEN D

  • Director
0 2020-06-22 0

FROST PHILLIP MD ET AL

  • Director
0 2020-06-22 0

MARTIN JAMES JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
0 2020-06-22 0

JAPOUR ANTHONY J

  • Director
0 2020-06-22 0

BRADY TODD R.

  • Director
0 2019-02-01 0

HSIAO JANE PH D

  • Director
0 2018-09-21 0

BLOCK DAVID S

  • Director
0 2018-09-21 0

FROST PHILLIP MD ET AL

FROST GAMMA INVESTMENTS TRUST

  • Director
  • 10% Owner
  • TRUSTEE
3,655,265 2018-05-03 0

MECKLER JEFFREY A CHIEF EXECUTIVE OFFICER

657,161 2016-03-15 0

DALE CURTIS INTERIM CFO

0 2015-11-24 0

MAYERS DOUGLAS L CHIEF MEDICAL OFFICER

0 2015-10-01 0

LINSCOTT WALT ADDISON GENERAL COUNSEL AND SECRETARY

0 2015-07-21 0

MCGUIRE GERALD A CHIEF FINANCIAL OFFICER

0 2015-04-13 0

OPKO HEALTH, INC.

  • 10% Owner
18,696,301 2014-03-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
COCRYSTAL PHARMA INC COCP 2021-07-28 17:45:03 UTC -8.9188 8.9988 2000000
COCRYSTAL PHARMA INC COCP 2021-07-28 17:15:03 UTC -8.9188 8.9988 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 16:45:03 UTC -8.9188 8.9988 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 16:15:02 UTC -8.9188 8.9988 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 15:45:03 UTC -8.9188 8.9988 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 15:15:03 UTC -8.9188 8.9988 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 14:45:02 UTC -8.9049 8.9849 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 14:15:03 UTC -8.9049 8.9849 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 13:45:02 UTC -8.9049 8.9849 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 13:15:03 UTC -8.9049 8.9849 1900000
COCRYSTAL PHARMA INC COCP 2021-07-28 12:45:03 UTC -8.9049 8.9849 1900000
COCRYSTAL PHARMA INC COCP 2021-07-27 22:15:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 21:45:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 21:15:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 20:45:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 20:15:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 19:45:02 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 19:15:02 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 18:45:03 UTC -8.9049 8.9849 2000000
COCRYSTAL PHARMA INC COCP 2021-07-27 18:15:02 UTC -8.9049 8.9849 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund COCP -21200.0 shares, $-29468.0 2021-03-31 N-PORT

Elevate your investments